Aletira is an emerging biotechnology company based on technologies created at Johns Hopkins University.
Aletira Therapeutics has raised $300K in total funding. The most recent round was Grant. The last funding was announced in April 2026.
Aletira Therapeutics's investors include TEDCO.
Aletira Therapeutics is headquartered in Baltimore, United States.
Aletira is an emerging biotechnology company based on technologies created at Johns Hopkins University.
Aletira Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aletira Therapeutics — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/aletira-therapeutics. Accessed October 6, 2026.
VCBacked. (2026). Aletira Therapeutics — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/aletira-therapeutics
{{cite web |title=Aletira Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aletira-therapeutics |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated